Liraglutide in whole-pancreas transplant patients with impaired glucose homoeostasis: A case series

Diabetes and Metabolism

Volumn 41, Issue 3, 2015, Pages 252-257

  Cariou, B ^a,b,c   Bernard, C ^a   Cantarovich, D ^c  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c L INSTITUT DU THORAX   (France)

Author keywords

GLP 1 receptor agonist; Pancreas transplantation; Type 1 diabetes

Indexed keywords

ACARBOSE; ACEBUTOLOL; AMLODIPINE; ATENOLOL; AZATHIOPRINE; CYCLOSPORIN A; DILTIAZEM; EVEROLIMUS; HEMOGLOBIN A1C; IMMUNOSUPPRESSIVE AGENT; INDAPAMIDE; LIRAGLUTIDE; MYCOPHENOLATE MOFETIL; PERINDOPRIL; PREDNISONE; RAMIPRIL; REPAGLINIDE; RILMENIDINE; TACROLIMUS; URAPIDIL; ANTIDIABETIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; DIARRHEA; DRUG DOSE TITRATION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE HOMEOSTASIS; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; LOSS OF APPETITE; MALE; MIDDLE AGED; NAUSEA; PANCREAS GRAFT REJECTION; PANCREAS TRANSPLANTATION; PROSPECTIVE STUDY; VOMITING; BODY WEIGHT; HYPERGLYCEMIA; PILOT STUDY;

ADULT; BODY WEIGHT; DIARRHEA; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; LIRAGLUTIDE; MALE; MIDDLE AGED; NAUSEA; PANCREAS TRANSPLANTATION; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 84937630074     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2014.10.004     Document Type: Article

References (7)

1. Gruessner R.W., Gruessner A.C. The current state of pancreas transplantation. Nat Rev Endocrinol 2013, 9:555-562.
2. Burron F., Thaunat O., Demuylder-Mischler S., Badet L., Brunet M., Ber C.E., et al. Pancreas retransplantation: a second chance for diabetic patients?. Transplantation 2013, 95:347-352.
3. Kielgast U., Krarup T., Holst J.J., Madsbad S. Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function. Diabetes Care 2011, 34:1463-1468.
4. Froud T., Faradji R.N., Pileggi A., Messinger S., Baidal D.A., Ponte G.M., et al. The use of exenatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy, and metabolic effects. Transplantation 2008, 86:36-45.
5. Faradji R.N., Froud T., Messinger S., Froud T., Pileggi A., Monroy K., et al. Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction. Cell Transplant 2009, 18:1247-1259.
6. Rickels M.R., Naji A. Reactive hypoglycaemia following GLP-1 infusion in pancreas transplant recipients. Diabetes Obes Metab 2010, 12:731-733.
7. Pinelli N.R., Patel A., Salinitri F.D. Coadministration of liraglutide with tacrolimus in kidney transplant recipients: a case series. Diabetes Care 2013, 36:e171-e172.